Retinal Detachment Market Research Report Information By Condition Type (Rhegmatogenous Retinal Detachment, Tractional Retinal Detachment, and Exudative Retinal Detachment), By Treatment (Photocoagulation (Laser Surgery), Cryopexy (Freezing), Pneumatic Retinopexy, Scleral Buckling, and Vitrectomy), By End User (Hospitals, Clinics, Specialty Centers, and Others), and By Region (North America, Europe, Asia-Pacific, and Rest Of The World) – Market Forecast Till 2032

Global Retinal Detachment Market Overview

Retinal Detachment Market Size was valued at USD 2.4 Billion in 2023. The Retinal Detachment Market Condition Type is projected to grow from USD 2.61 Billion in 2024 to USD 4.7 Billion by 2032, exhibiting a compound annual growth rate (CAGR) of 7.62% during the forecast period (2024 - 2032). Rising prevalence of geriatrics, diabetic retinopathy, and other eye conditions are the key market drivers enhancing the market growth.

Source Secondary Research, Primary Research, MRFR Database and Analyst Review

Retinal Detachment Market Trends

• Increasing geriatric population is driving the market growth

The market is expanding as a result of elements such an ageing population, a rise in the prevalence of eye conditions like diabetic retinopathy, as well as other factors. For instance, the CDC estimates that approximately 20.5 million Americans aged 40 and older have a cataract in at least one eye, and that figure is expected to increase to 30 million by 2028. Thus, the anticipated rise in the number of cataract patients increases the demand for successful surgical techniques and treatment alternatives, which is expected to drive market expansion over the course of the forecast period.

Additionally, as the prevalence of diabetes grows, so too will the chance of developing diabetic retinopathy, which will drive up the demand for efficient therapies and propel the market forward. For instance, the IDF's 2022 estimates show that there were approximately 537 million diabetics worldwide in 2021, and that number is projected to increase to 643 million in 2030 and 784 million in 2045.Therefore, the anticipated increase in the number of people with diabetes will be the primary factor driving market growth over the next few years.

Additionally, more people are becoming educated about eye conditions like glaucoma, dry eye disease, and cataracts. The market is anticipated to expand over the next years as a result of the increased demand for eye treatments. For instance, according to a June 2021 article in Healthcare, a survey was conducted to determine how much the general public in the Hail Region in Saudi Arabia knew about common eye issues and what can cause them between November 15, 2020, and January 15, 2021.31% of those who participated in the study were aware of cataracts, 43% were aware of glaucoma, 66% were aware of dry eyes, and 44% were aware of diabetic retinopathy. The same source also claimed that 46% of the participants were aware of eye diseases, with men being more knowledgeable than women.

Growing technological advancements and a rise in retinal detachment cases are the two main reasons projected to propel market expansion for the  retinal detachment disease market. The rise in eye operations is also anticipated to fuel market expansion. Additionally, the market is expanding due to factors such an ageing population, an increase in the frequency of diabetic retinopathy, and other eye illnesses. Additionally, as more people become aware of eye problems including cataracts, glaucoma, dry eye disease, and others, the need for eye therapies rises. This is expected to hasten market growth throughout the course of the forecast year. Thus, driving the Retinal Detachment market revenue.

Retinal Detachment Market Segment Insights

Retinal Detachment Condition Type Insights

The Retinal Detachment market segmentation, based on Condition Type, includes rhegmatogenous retinal detachment, tractional retinal detachment, and exudative retinal detachment. Rhegmatogenous retinal detachment segment dominated the  market in 2022. This is because rhegmatogenous retinal detachment is becoming more common among the senior population. The number of RRD patients is expected to rise along with the  ageing population, and early disorder discovery helps patients avoid financial hardship as a result, according to the United Nations' 2017 "World Ageing Population" research. According to estimates, 10 to 18 out of every 100,000 people in the United States experience rhegmatogenous retinal detachment (RRD), a condition that could impair eyesight.

Retinal Detachment Treatment Insights

The Retinal Detachment market segmentation, based on Treatment, includes photocoagulation (laser surgery), cryopexy (freezing), pneumatic retinopexy, scleral buckling, and vitrectomy. Vitrectomy segment dominated the market in 2022. This is due to elements like the increased prevalence of retinal illness and the increasing burden of diabetic retinopathy.

Retinal Detachment End User Insights

The Retinal Detachment market segmentation, based on End User, includes hospitals, clinics, specialty centers, and others. Hospitals segment dominated the Retinal Detachment market in 2022. This is a result of the variety of retinal detachment treatments accessible, such as surgery, laser therapy, and cryotherapy (freezing) in the hospital sector, which may increase the market share throughout the course of the projected period. Additionally, hospitals with contemporary infrastructure and adequate resources are able to treat the growing number of individuals who suffer from this ailment.

Figure 1 Retinal Detachment Market, by End User, 2022 & 2032 (USD Billion)

Source Secondary Research, Primary Research, MRFR Database and Analyst Review

Retinal Detachment Regional Insights

By region, the study provides the market insights into North America, Europe, Asia-Pacific and Rest of the World. The North America Retinal Detachment Market dominated this market in 2022 (45.80%). This is due to a variety of factors, including beneficial government initiatives, an increase in research collaborations, the presence of important players, the high prevalence of diabetes-related comorbidities in the area, the ageing of the population, and the region's solid healthcare system. By May 2021, diabetic retinopathy, for instance, will be the main cause of vision loss and blindness in adults in the working age group in the United States, according to data from the CDC. It is anticipated that 14.6 million Americans would develop diabetic retinopathy by 2050. Further, the U.S. Retinal Detachment market held the largest market share, and the Canada Retinal Detachment market was the fastest growing market in the North America region.

Further, the major countries studied in the market report are The US, Canada, German, France, the UK, Italy, Spain, China, Japan, India, Australia, South Korea, and Brazil.

Figure 2 RETINAL DETACHMENT MARKET SHARE BY REGION 2022 (USD Billion)

Source Secondary Research, Primary Research, MRFR Database and Analyst Review

Europe Retinal Detachment market accounted for the healthy market share in 2022. The demand for retinal eye therapy is projected to rise due to the region's rising diabetes prevalence, which will boost the local market. Further, the German Retinal Detachment market held the largest market share, and the U.K Retinal Detachment market was the fastest growing market in the European region

The Asia Pacific Retinal Detachment market is expected to register significant growth from 2024 to 2032. This is due to the rising number of patients with retinal detachments and increased awareness of the problem in this area. Moreover, China’s Retinal Detachment market held the largest market share, and the Indian Retinal Detachment market was the fastest growing market in the Asia-Pacific region.

Retinal Detachment Key Market Players & Competitive Insights

Leading market players are investing heavily in research and development in order to expand their product lines, which will help the Retinal Detachment market grow even more. Market participants are also undertaking a variety of strategic activities to expand their footprint, with important market developments including new product launches, contractual agreements, mergers and acquisitions, higher investments, and collaboration with other organizations. To expand and survive in a more competitive and rising market climate, Retinal Detachment Industry must offer cost-effective items.

Manufacturing locally to minimize operational costs is one of the key business tactics used by manufacturers in the Retinal Detachment Industry to benefit clients and increase the market sector. In recent years, the Retinal Detachment Industry has offered some of the most significant advantages to medicine. Major players in the Retinal Detachment market, including Carl Zeiss Meditec AG, Meridian AG, IRIDEX Corporation, Ellex Medical Lasers Ltd, FCI, Millennium Surgical Corp., BVM Medical Limited, Lombart Instrument, Inc., and Welch Allyn, are attempting to increase market demand by investing in research and development operations.

A subsidiary of Carl Zeiss Stiftung AG, Carl Zeiss AG (Carl Zeiss) is a medical technology firm that produces and sells optical and optoelectronic equipment. The company's product line includes binoculars, camera and cine lenses, eyeglass lenses, measurement technologies, photomask systems, microscopes, and medical technology goods including ophthalmic diagnostic and therapeutic equipment. Additionally, it provides planetarium software for use in sky theatres, star theatres, and universe theatres on small, medium, and large projection equipment. It provides services to many industries, including semiconductor, automotive, mechanical, biomedical, and medical technology. EMEA, the Americas, and APAC are regions where the corporation operates. The headquarters of Carl Zeiss are in Oberkochen, Germany. To further enhance its position in the market, Carl Zeiss Meditec bought two surgical tool producers in April 2022 Kogent Surgical, LLC and Katalyst Surgical, LLC.

ASG Eye Hospitals is the owner of a network of specialised eye clinics designed to serve patients from all across India. In order to help patients regain their eyesight, the organisation offers a broad variety of eye care treatments for cataracts, diabetic retinopathy, glaucoma, macular degeneration, and eye tumours. ASG Eye Hospitals opened a new specialist eye facility in Vashi, Navi Mumbai, in December 2022 to treat even the most severe eye conditions. The hospital provides scleral buckling operations, vitrectomy treatments, and pneumatic retinopexy procedures for retinal detachment.

Key Companies in the Retinal Detachment market include

• Carl Zeiss Meditec AG


• Meridian AG


• IRIDEX Corporation


• Ellex Medical Lasers Ltd


• FCI


• Millennium Surgical Corp.


• BVM Medical Limited


• Lombart Instrument, Inc.


• Welch Allyn

Retinal Detachment Industry Developments

October 2021 Tennessee Retina, which operates in nine locations including Nashville, Bowling Green, and Crossville, has been added to Retina Consultants of America (RCA), a business that aids physicians in managing their practises.

Retinal Detachment Market Segmentation

Retinal Detachment Condition Type Outlook

• Rhegmatogenous Retinal Detachment


• Tractional Retinal Detachment


• Exudative Retinal Detachment

Retinal Detachment Treatment Outlook

• Photocoagulation (Laser Surgery)


• Cryopexy (Freezing)


• Pneumatic Retinopexy


• Scleral Buckling


• Vitrectomy

Retinal Detachment End User Outlook

• Hospitals and Clinics


• Specialty Centers


• Others

Retinal Detachment Regional Outlook

• North America
  
  
  
  • US
  
  
  • Canada
  
  
  
  


• Europe
  
  
  
  • Germany
  
  
  • France
  
  
  • UK
  
  
  • Italy
  
  
  • Spain
  
  
  • Rest of Europe
  
  
  
  


• Asia-Pacific
  
  
  
  • China
  
  
  • Japan
  
  
  • India
  
  
  • Australia
  
  
  • South Korea
  
  
  • Australia
  
  
  • Rest of Asia-Pacific
  
  
  
  


• Rest of the World
  
  
  
  • Middle East
  
  
  • Africa
  
  
  • Latin America